| 1997 |
ARPC1A (SOP2Hs) is a component of the mammalian Arp2/3 complex in human neutrophils, and the complex localizes to lamellipodia upon stimulation with serum or PDGF, implicating it in actin cytoskeleton organization at sites of protrusion. |
Peptide sequencing, cDNA cloning, subcellular localization by immunofluorescence in fibroblasts |
The Biochemical journal |
Medium |
9359840
|
| 1999 |
Arc40p (yeast ARPC1A ortholog) is an essential component of the yeast Arp2/3 complex; immunoprecipitation confirmed its association, and deletion showed it is required for cell viability, cortical actin patch assembly, and complex integrity (Arc15p is required for association of Arp2p and Arc40p with the complex). |
Immunoprecipitation, gel-filtration, gene disruption, actin patch microscopy |
Proceedings of the National Academy of Sciences of the United States of America |
High |
10377407
|
| 2001 |
ARC40 (yeast ARPC1A ortholog) has synthetic genetic interactions with cytoskeletal organization genes (BNI1, ARP2, BIM1), placing it in the cortical actin assembly pathway. |
Synthetic genetic array (SGA) analysis — systematic double-mutant construction in yeast |
Science (New York, N.Y.) |
Low |
11743205
|
| 2004 |
ARPC1/Arc40 binds the VCA domain of WASp family activators (Kd ~0.45 µM for recombinant Arc40, close to 0.30 µM for full complex); loss of Arc40 in Δarc40 yeast severely reduces Arp2/3 complex binding affinity for VCA and nucleation activity, and causes loss of actin patches with accumulation of actin cables, demonstrating that Arc40 is an essential VCA contact site. |
Recombinant protein binding assay, VCA-pulldown, in vitro actin nucleation assay, yeast genetic deletion, actin patch microscopy |
The Journal of biological chemistry |
High |
15485833
|
| 2009 |
ARPC1A is identified as a direct binding partner of Hsp27 by immunoaffinity purification/mass spectrometry; thiolutin treatment disrupts this interaction and induces peripheral co-localization of phospho-Hsp27 and Arp2/3, linking ARPC1A–Hsp27 interaction to cytoskeletal regulation in endothelial cell adhesion. |
Immunoaffinity purification, mass spectrometry, immunofluorescence localization |
Cell stress & chaperones |
Medium |
19579057
|
| 2009 |
ARPC1A silencing by RNAi in AsPC-1 pancreatic cancer cells (which harbor 7q21-q22 amplification) causes a massive reduction in cell migration and invasion, with only a slight decrease in proliferation, establishing ARPC1A as a regulator of cell motility downstream of actin polymerization. |
RNAi knockdown, cell migration assay, invasion assay, cell proliferation assay, FISH copy-number analysis, qRT-PCR |
Genes, chromosomes & cancer |
Medium |
19145645
|
| 2010 |
Structure-function analysis of yeast p40/ARPC1 identified three distinct functional surfaces: (1) contact with p19/ARPC4 required for WASp-induced nucleation; (2) contact with p15/ARPC5 that suppresses spontaneous (leaky) nucleation; (3) an extended structural arm that directly binds the VCA domain of WASp and is required for actin nucleation. Lethal alleles at each site produced distinct biochemical defects in purified Arp2/3 complexes. |
Systematic in vivo allele analysis (39 integrated alleles), purification of mutant Arp2/3 complexes, in vitro actin nucleation assay, VCA binding assay |
The Journal of biological chemistry |
High |
20071330
|
| 2017 |
Loss of ARPC1B leads to compensatory upregulation of ARPC1A in patient platelets, but ARPC1B-deficient cells cannot support WASP-mediated ARP2/3 nucleation despite elevated ARPC1A, indicating that ARPC1A and ARPC1B are not functionally interchangeable within the ARP2/3 complex in blood cells. |
Patient-derived platelet lysate analysis, immunoblot, functional platelet spreading assays, megakaryocytic cell knockout |
Nature communications |
High |
28368018
|
| 2021 |
Despite upregulation of ARPC1A in ARPC1B-deficient cells, ARP2/3 complexes containing ARPC1A cannot be stimulated by WASP to nucleate branched actin; this isoform-specific deficiency leads to loss of WASP-dependent structures (podosomes, lamellipodia) and weakening of cortical F-actin, resulting in increased BCR diffusion, elevated tonic lipid signaling, oscillatory calcium release, and phospho-Akt in B cells. |
Patient B cell analysis, immunoblot, F-actin imaging, BCR diffusion assay, calcium imaging, phospho-signaling readout |
JCI insight |
High |
34673575
|
| 2022 |
STAT3 transcriptionally regulates ARPC1A expression in prostate cancer cells; ARPC1A knockdown promotes ferroptosis and reduces cell viability and invasion, as established by Co-IP, ChIP, and luciferase reporter assays confirming STAT3 binding to the ARPC1A promoter. |
Co-IP, ChIP, luciferase reporter assay, RNAi knockdown, ferroptosis assay, in vivo tumor model |
Human cell |
Medium |
35871131
|
| 2024 |
ARPC1A-containing ARP2/3 iso-complexes are inhibited by both CK-666 and CK-869 for actin branching, whereas ARPC1B-containing complexes are only inhibited by CK-869; both inhibitors block linear actin filament formation in ARPC1A- and ARPC1B-containing complexes when activated by SPIN90. This demonstrates isoform-specific pharmacology of ARP2/3 complexes. |
Reconstituted recombinant Arp2/3 iso-complexes with defined subunit composition, in vitro actin polymerization/branching assays with pharmacological inhibitors, macrophage phagocytosis and migration assays |
EMBO reports |
High |
39009834
|
| 2024 |
ARPC1A inactivation (KD or KO) combined with inactivation of arpin and CYFIP2 synergistically enhances cortical branched actin polymerization and migration persistence in human MCF10A cells and zebrafish endodermal cells, identifying ARPC1A as a negative regulator of cortical branched actin in the Rac1-WAVE-Arp2/3 migration pathway. |
siRNA knockdown, CRISPR knockout, live cell migration assay, zebrafish in vivo migration, vimentin re-expression rescue experiment |
Journal of cell science |
Medium |
38059420
|
| 2024 |
EML4 interacts with ARPC1A to modulate cytoskeletal dynamics and enhance lamellipodia formation, cellular motility, local invasion, and metastasis in lung adenocarcinoma; m6A hypermethylation of EML4 mRNA promotes its translation leading to ARPC1A interaction. |
m6A epitranscriptomic profiling, co-immunoprecipitation (EML4–ARPC1A interaction), functional migration/invasion assays, in vivo metastasis model |
Cancer discovery |
Medium |
38922581
|
| 2016 |
ARPC1A was identified as a component of the PKD2 interaction network; chemical cross-linking/mass spectrometry detected ARPC1A (along with the full Arp2/3 complex) as a PKD2-interacting protein in cytosolic and Golgi-enriched fractions, suggesting a direct protein–protein interaction. |
Affinity enrichment, chemical cross-linking, mass spectrometry |
Journal of proteome research |
Low |
27559607
|